Phase 2 Study of RSLV-132 in Subjects With Long COVID

Complete Title: A Phase 2, Double-Blind, Placebo-Controlled Study of RSLV-132 in Subjects with Post-acute COVID-19 (long covid)
Trial Phase:
Investigator: James Andrews, MD

The purpose of this study is to assess the efficacy (decrease in severe fatigue), safety and pharmacokinetics of RSLV-132 in subjects with long Corona Virus (COVID) syndome

Keywords:
  • COVID-19
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

Adult
James Andrews, MD
RG1121598
NCT04944121
A Phase 2, Double-Blind, Placebo-Controlled Study of RSLV-132 in Subjects with Post-acute COVID-19 (long covid)
COVID-19